A previous study that retrospectively investigated the expression of all HER receptors using IHC and FISH, in a cohort of 48 patients with advanced breast cancer treated with trastuzumab, reported a significant positive impact of HER4 expression on survival [50]. The gene discussed is ERBB4; the disease is breast cancer.